title: Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems.
authors.affiliation: Office of Medical Policy, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
authors.forename: Carlos
authors.initials: C
authors.lastname: Bell
authors.forename: Aloka
authors.initials: A
authors.lastname: Chakravarty
authors.forename: Susan
authors.initials: S
authors.lastname: Gruber
authors.forename: Susan R
authors.initials: SR
authors.lastname: Heckbert
authors.forename: Mark
authors.initials: M
authors.lastname: Levenson
authors.forename: David
authors.initials: D
authors.lastname: Martin
authors.forename: Jennifer C
authors.initials: JC
authors.lastname: Nelson
authors.forename: Simone
authors.initials: S
authors.lastname: Pinheiro
authors.forename: Bruce M
authors.initials: BM
authors.lastname: Psaty
authors.forename: Christian G
authors.initials: CG
authors.lastname: Reich
authors.forename: Sebastian
authors.initials: S
authors.lastname: Schneeweiss
authors.forename: Azadeh
authors.initials: A
authors.lastname: Shoaibi
authors.forename: Sengwee
authors.initials: S
authors.lastname: Toh
authors.forename: Alexander M
authors.initials: AM
authors.lastname: Walker
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000706:statistics & numerical data*; D000799:Angioedema / Q000139:chemically induced*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D057286:Electronic Health Records / Q000706:statistics & numerical data; D006801:Humans; D017891:Pharmacoepidemiology; D012107:Research Design
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors
keywords: electronic medical records; insurance claims; pharmacoepidemiology; safety surveillance